Related Experiment Video
Updated: Jul 18, 2026

Development of Leishmania Species Strains with Constitutive Expression of eGFP
Published on: April 21, 2023
[Last updates on leishmania vaccine studies: when are we going to be vaccinated?]
1Ege Üniversitesi Tıp Fakültesi Parazitoloji AD, İzmir, Turkey.
Abstract:
Approximately 350 million people in 8 countries are estimated to be under the threat of leishmaniasis. Most of the drugs used for the treatment of leishmaniasis are toxic and have many side effects. At present there is no vaccine against leishmaniasis. Vaccine development for parasitic infections is more difficult than for viruses and bacteria because of the antigenic complexity and parasite-host interactions. Anti-leishmanial vaccine candidates are reviewed in this paper.
Related Concept Videos
Leishmaniasis
Antiprotozoal Agents
Vaccinations
Vaccines
Vaccine Production
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

